379 The AKT/mTORC1 axis influences the functional transformation of non-parenchymal cells
Even injection users find tablets appealing More than two thirds ( 71.88% ) of previous GLP-1 injection users said a daily tablet feels more appealing than a weekly injection, while 66.67% of current injection users agreed, showing strong interest in oral options even among experienced users
95% CI 11.72, 0.28) were associated with associated with significantly lower LH compared to placebo (Fig
Are PeterMDs providers and pharmacies legit
New data from IGD and NIQ reveals a growing need for retailers to adapt to the GLP-1 uptake, as the broader household impact is made cle ar London, 22nd July 2026: Latest research from the Institute of Grocery Distribution (IGD), a grocery insight and foresight organisation and NIQ (NYSE: NIQ), a global consumer intelligence company, reveals that 8% of individuals in the UK use GLP-1 medication, a 3.1% increase over the past nine months 1